{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:00:23Z","timestamp":1781197223946,"version":"3.54.1"},"reference-count":26,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["FORTE: grant 2015-00304"],"award-info":[{"award-number":["FORTE: grant 2015-00304"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["Grant: 20160508"],"award-info":[{"award-number":["Grant: 20160508"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,8,12]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>About 90% of active tuberculosis (TB) cases in Sweden are foreign born and are mainly due to latent TB infection (LTBI) reactivation. The aim of this study was to assess the current migrant LTBI screening programme with regards to test results and completion of the care cascade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective cohort of all 14173 individuals attending a health examination was established for the Stockholm Region 2015\u20132018 through record-linkage of data extracted from the Swedish Migration Authority and medical records. Screening results, referrals to specialist care and treatment initiation were ascertained through automated data extraction for the entire cohort. Detailed cascade steps, including treatment completion, were analysed through manual data extraction for a subsample of all persons referred to specialist care in the period 2016\u20132017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 5470 patients screened with an interferon-gamma release assay (IGRA), 1364 (25%) were positive, of whom 358 (26%) initiated LTBI treatment. An increased trend in IGRA-positivity was seen for increased age and TB-incidence in country of origin. Among the IGRA positive patients, 604 (44%) were referred to specialist care. Lower age was the main referral predictor. In the subsample of 443 patients referred to specialist care in 2016\u20132017, 386 (87%) were invited, of whom 366 (95%) attended. Of 251 patients (69%) recommended for LTBI treatment, 244 (97%) started such treatment and of those 221 (91%) completed it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The low attrition in patient-dependent cascade steps shows that the voluntary approach works well. Low LTBI treatment attainment is due to the current conservative local treatment policy, which means the vast majority are IGRA-tested without an intention to treat for LTBI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.02255-2020","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T13:20:49Z","timestamp":1598534449000},"page":"2002255","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015\u20132018: a record linkage study of the care cascade"],"prefix":"10.1183","volume":"57","author":[{"given":"Joanna","family":"Nederby \u00d6hd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Pia","family":"Hergens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yauheni","family":"Luksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Shedrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-6176","authenticated-orcid":false,"given":"Jerker","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"L\u00f6nnroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"2026061109104796000_57.3.2002255.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00214014"},{"key":"2026061109104796000_57.3.2002255.2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5588\/ijtld.16.0845","article-title":"Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points","volume":"21","author":"Lonnroth","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026061109104796000_57.3.2002255.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152"},{"key":"2026061109104796000_57.3.2002255.4","doi-asserted-by":"crossref","first-page":"30325","DOI":"10.2807\/1560-7917.ES.2016.21.34.30325","article-title":"Identifying components for programmatic latent tuberculosis infection control in the European Union","volume":"21","author":"Sandgren","year":"2016","journal-title":"Euro Surveill"},{"key":"2026061109104796000_57.3.2002255.5","unstructured":"Folkh\u00e4lsomyndigheten [The Swedish Public Health Agency] . Tuberkulos 2018 [Tuberculosis 2018]. www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/tuberkulos\/ Date last accessed: January 09, 2020. Date last updated: May 16, 2019."},{"key":"2026061109104796000_57.3.2002255.6","unstructured":"Jonsson J . Tuberculosis control in Sweden . Stockholm, Karolinska Institutet, 2018. https:\/\/openarchive.ki.se\/xmlui\/bitstream\/handle\/10616\/46472\/Thesis_Jerker_Jonsson.pdf?sequence=1&isAllowed=y"},{"key":"2026061109104796000_57.3.2002255.7","unstructured":"Sveriges Riksdag [Swedish Parliament] . Lag (2008:344) om h\u00e4lso- och sjukv\u00e5rd \u00e5t asyls\u00f6kande m.fl [Law on healthcare for asylum seekers and others]. Stockholm , Ministry of Justice, 2008. www.riksdagen.se\/sv\/dokument-lagar\/dokument\/svensk-forfattningssamling\/lag-2008344-omhalso--och-sjukvard-at_sfs-2008-344 Date last accessed: February 22, 2019. Date last updated: May 22, 2008."},{"key":"2026061109104796000_57.3.2002255.8","unstructured":"Region Stockholm . Prover som ing\u00e5r i en h\u00e4lsounders\u00f6kning [Samples included in a health examination]. Stockholm, Region Stockholm, 2019. www.vardgivarguiden.se\/globalassets\/kunskapsstod\/smittskydd\/asyl-halsoundersokning\/tester-som-ingar-i-en-halsoundersokning.pdf Date last accessed: January 09, 2020. Date last updated: November 25, 2019."},{"key":"2026061109104796000_57.3.2002255.9","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0692"},{"key":"2026061109104796000_57.3.2002255.10","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.ijid.2019.02.041","article-title":"Building a European database to gather multi-country evidence on active and latent TB screening for migrants","volume":"80","author":"Ohd","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2026061109104796000_57.3.2002255.11","unstructured":"Folkh\u00e4lsomyndigheten [The Swedish Public Health Agency] . Riskl\u00e4nder f\u00f6r tuberkulos 2019 [Risk countries for tuberculosis 2019]. www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/vacciner-a-o\/hepatit-b\/risklander-tuberkulos-och-hepatit-b\/ Date last accessed: February 12, 2021. Date last updated: September 03, 2020."},{"key":"2026061109104796000_57.3.2002255.12","unstructured":"World Health Organization (WHO) . Global tuberculosis report 2018. Geneva, WHO, 2018. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646-eng.pdf?sequence=1&isAllowed=y"},{"key":"2026061109104796000_57.3.2002255.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00861-2019"},{"key":"2026061109104796000_57.3.2002255.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01245-2015"},{"key":"2026061109104796000_57.3.2002255.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"2026061109104796000_57.3.2002255.16","first-page":"17-00543","article-title":"The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU\/EEA: a systematic review","volume":"23","author":"Greenaway","year":"2018","journal-title":"Euro Surveill"},{"key":"2026061109104796000_57.3.2002255.17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/inthealth\/ihy007","article-title":"\u2018Valuable but incomplete!\u2019 A qualitative study about migrants\u2019 perspective on health examinations in Stockholm","volume":"10","author":"Shedrawy","year":"2018","journal-title":"Int Health"},{"key":"2026061109104796000_57.3.2002255.18","unstructured":"Migrationsverket [Swedish Migration Agency] . Asyl statistik [Asylum statistics]. www.migrationsverket.se\/Om-Migrationsverket\/Statistik\/Asyl.html Date last accessed: February 10, 2021. Date last updated: February 08, 2021."},{"key":"2026061109104796000_57.3.2002255.19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12955-019-1228-4","article-title":"Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden","volume":"17","author":"Shedrawy","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"2026061109104796000_57.3.2002255.20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/23744235.2018.1459046","article-title":"High rate of latent tuberculosis treatment completion in immigrants seeking asylum in Sweden","volume":"50","author":"Olsson","year":"2018","journal-title":"Infect Dis (Lond)"},{"key":"2026061109104796000_57.3.2002255.21","unstructured":"Folkh\u00e4lsomyndigheten [The Swedish Public Health Agency] . Guidelines for prevention and control of tuberculosis. www.folkhalsomyndigheten.se\/contentassets\/92e06754e3464636b1bdbb980378bcf3\/rekommendationer-for-preventiva-insatser-mot-tuberkulos.pdf Date last accessed: February 10, 2021. Date last updated: June 04, 2020."},{"key":"2026061109104796000_57.3.2002255.22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5588\/ijtld.16.0935","article-title":"Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection","volume":"21","author":"Zenner","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026061109104796000_57.3.2002255.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01449-2018"},{"key":"2026061109104796000_57.3.2002255.24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5588\/ijtld.17.0036","article-title":"Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results","volume":"21","author":"Kunst","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026061109104796000_57.3.2002255.25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5588\/ijtld.17.0503","article-title":"Defining a migrant-inclusive tuberculosis research agenda to end TB","volume":"22","author":"Shete","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026061109104796000_57.3.2002255.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02604-2017"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02255-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:11:11Z","timestamp":1781194271000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02255-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,18]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1183\/13993003.02255-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02255-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}